Advertiment
ASHP Advantage has launched an educational initiative on optimizing bone health in cancer patients. This initiative is designed to address educational needs of health-system pharmacists, enabling them to take an active role in optimizing bone health in cancer patients.
Improvements in cancer treatment have increased survival and the need for effective interventions to reduce the risk for skeletal-related events. Many cancer therapies cause bone loss, increasing the risk for fractures. Bisphosphonates are one useful treatment for bone metastases and slowing or preventing cancer treatment-induced bone loss (CTIBL). RANK-ligand Inhibitors have also been shown to decrease skeletal-related events in patients with bone metastases from solid tumors. Other agents for the treatment of bone metastases are under investigation. Knowledge of the role of current agents and how new and emerging bone-targeted therapies can be used in treating patients with bone metastases or CTIBL will enable pharmacists to take an active role in the management of these patients.
The initiative portal, optimizingbonehealth.com, serves as the cornerstone of the initiative and includes many resources and links to a variety of educational activities including a live, interactive webinar, an on-demand, web-based home study activity, and an informative podcast. In additional, pharmacists will be able to register for live educational activities. All activities were developed by oncology content matter experts and supported by an educational grant from Novartis Oncology.
Source:
ASHP Advantage
ASHP
Leave a Reply
Suggested Posts
3-D RNA Modeling Opens Scientific Doors ASHP Adva tage has lau ched a educatio al i itiative o optimizi g bo e health i ca cer patie ts. This i itiative is desig ed to address educatio al eeds of health-system pharmacists, e abli g them to take a active role i optimizi g bo e health i ca cer patie ts. Improveme ts i ca cer treatme t have i creased survival a d the eed for effective i terve tio s to reduce the [...]. Posted April 26th, 2011 | 2:52 am
Potential New Treatment For Kidney Cancer By Specific Inhibition Of Autophagy ASHP Adva tage has lau ched a educatio al i itiative o optimizi g bo e health i ca cer patie ts. This i itiative is desig ed to address educatio al eeds of health-system pharmacists, e abli g them to take a active role i optimizi g bo e health i ca cer patie ts. Improveme ts i ca cer treatme t have i creased survival a d the eed for effective i terve tio s to reduce the [...]. Posted April 26th, 2011 | 2:52 am
Altering Tumor Microenvironment Shown To Boost Response To Cancer Drugs During Live Imaging ASHP Adva tage has lau ched a educatio al i itiative o optimizi g bo e health i ca cer patie ts. This i itiative is desig ed to address educatio al eeds of health-system pharmacists, e abli g them to take a active role i optimizi g bo e health i ca cer patie ts. Improveme ts i ca cer treatme t have i creased survival a d the eed for effective i terve tio s to reduce the [...]. Posted April 26th, 2011 | 2:52 am
Cancer Gene MCL1 Targeted ASHP Adva tage has lau ched a educatio al i itiative o optimizi g bo e health i ca cer patie ts. This i itiative is desig ed to address educatio al eeds of health-system pharmacists, e abli g them to take a active role i optimizi g bo e health i ca cer patie ts. Improveme ts i ca cer treatme t have i creased survival a d the eed for effective i terve tio s to reduce the [...]. Posted April 26th, 2011 | 2:52 am
Study Finds Cancer Related Pain Often Under-Treated ASHP Adva tage has lau ched a educatio al i itiative o optimizi g bo e health i ca cer patie ts. This i itiative is desig ed to address educatio al eeds of health-system pharmacists, e abli g them to take a active role i optimizi g bo e health i ca cer patie ts. Improveme ts i ca cer treatme t have i creased survival a d the eed for effective i terve tio s to reduce the [...]. Posted April 26th, 2011 | 2:52 am